LHM Inc. Buys New Position in SPDR S&P Biotech ETF (NYSEARCA:XBI)

LHM Inc. bought a new stake in shares of SPDR S&P Biotech ETF (NYSEARCA:XBI) during the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission. The institutional investor bought 19,174 shares of the exchange traded fund’s stock, valued at approximately $1,712,000. SPDR S&P Biotech ETF makes up approximately 1.5% of LHM Inc.’s holdings, making the stock its 3rd largest holding.

Other hedge funds also recently added to or reduced their stakes in the company. Verity Asset Management Inc. increased its holdings in shares of SPDR S&P Biotech ETF by 7.9% in the third quarter. Verity Asset Management Inc. now owns 17,228 shares of the exchange traded fund’s stock valued at $1,258,000 after purchasing an additional 1,266 shares during the period. Prime Capital Investment Advisors LLC increased its holdings in shares of SPDR S&P Biotech ETF by 52.6% in the fourth quarter. Prime Capital Investment Advisors LLC now owns 6,464 shares of the exchange traded fund’s stock valued at $577,000 after purchasing an additional 2,228 shares during the period. United Capital Management of KS Inc. increased its holdings in shares of SPDR S&P Biotech ETF by 1.8% in the fourth quarter. United Capital Management of KS Inc. now owns 104,048 shares of the exchange traded fund’s stock valued at $9,290,000 after purchasing an additional 1,831 shares during the period. Albion Financial Group UT acquired a new position in shares of SPDR S&P Biotech ETF in the fourth quarter valued at about $69,000. Finally, Parsons Capital Management Inc. RI acquired a new position in shares of SPDR S&P Biotech ETF in the fourth quarter valued at about $237,000.

SPDR S&P Biotech ETF Trading Down 3.4 %

Shares of XBI stock traded down $3.13 during mid-day trading on Friday, reaching $88.15. The stock had a trading volume of 14,306,219 shares, compared to its average volume of 11,713,061. SPDR S&P Biotech ETF has a 1-year low of $63.80 and a 1-year high of $103.52. The firm has a market cap of $6.76 billion, a price-to-earnings ratio of 11.47 and a beta of 0.97. The business’s fifty day moving average is $93.99 and its 200-day moving average is $83.88.

SPDR S&P Biotech ETF Company Profile

SPDR S&P Biotech ETF (the Fund) seeks to closely match the returns and characteristics of the S&P Biotechnology Select Industry Index. The S&P Biotechnology Select Industry Index represents the biotechnology sub-industry portion of the S&P Total Markets Index. The S&P TMI tracks all the United States common stocks listed on the New York Stock Exchange, American Stock Exchange, National Association of Securities Dealers Automated Quotation (NASDAQ) National Market and NASDAQ Small Cap exchanges.